rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2000-11-15
|
pubmed:abstractText |
Interleukin-18 (IL-18) is a novel proinflammatory cytokine. Most of the immune and inflammatory genes induced by IL-18 are nuclear factor-kappaB (NF-kappaB)- and activator protein-1 (AP-1)-regulated. Interleukin-1 receptor-associated kinase-1 (IRAK-1) has recently been shown to be involved in IL-18-stimulated activation of NF-kappaB and AP-1. The purpose of this study is to investigate the effects of preventing IRAK-1 expression by antisense IRAK-1 oligodeoxynucleotide (ODN) on IL-18-stimulated activation of NF-kappaB and AP-1. Semiquantitative reverse transcription-PCR (RT-PCR) and western blot analysis revealed that antisense IRAK-1 ODN inhibited IRAK-1 mRNA and protein expression (P<0.01). As a result, antisense IRAK-1 ODN attenuated IL-18-induced activation of NF-kappaB and AP-1 as measured by sandwich ELISA in a concentration (1-8 microg ml(-1))- and time (5-24 h)-dependent fashion. These data suggest that antisense IRAK-1 ODN may share a role in the design of antiinflammatory therapeutics.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1 Receptor-Associated...,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-18,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/Oligonucleotides, Antisense,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factor AP-1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0162-3109
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
241-6
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:10996021-Enzyme Activation,
pubmed-meshheading:10996021-Enzyme Inhibitors,
pubmed-meshheading:10996021-Gene Expression Regulation,
pubmed-meshheading:10996021-Humans,
pubmed-meshheading:10996021-Interleukin-1 Receptor-Associated Kinases,
pubmed-meshheading:10996021-Interleukin-18,
pubmed-meshheading:10996021-NF-kappa B,
pubmed-meshheading:10996021-Oligonucleotides, Antisense,
pubmed-meshheading:10996021-Protein Kinase Inhibitors,
pubmed-meshheading:10996021-Protein Kinases,
pubmed-meshheading:10996021-Receptors, Interleukin-1,
pubmed-meshheading:10996021-Transcription Factor AP-1,
pubmed-meshheading:10996021-Tumor Cells, Cultured
|
pubmed:year |
2000
|
pubmed:articleTitle |
Antisense IRAK-1 oligonucleotide blocks activation of NF-kappa B and AP-1 induced by IL-18.
|
pubmed:affiliation |
Institute of Pharmaceutic Sciences, The First Military Medical University, 510515, Guang Zhou, People's Republic of China.
|
pubmed:publicationType |
Journal Article
|